| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHL1900120 | 多替拉韦拉米夫定片 | DOLUTEGRAVIR SODIUM;LAMIVUDINE | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-06-03 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2019-06-01 | view |
| JXHS1900147 | 多替拉韦拉米夫定片 | DOLUTEGRAVIR SODIUM;LAMIVUDINE | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-11-23 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-04 | view |